Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1971 2
1972 3
1973 3
1975 2
1977 2
1978 1
1979 4
1980 5
1981 6
1982 12
1983 1
1984 1
1985 2
1986 2
1987 3
1988 8
1989 2
1990 2
1991 1
1992 3
1993 2
1994 2
1995 2
1996 1
1998 1
1999 2
2000 3
2001 2
2002 3
2003 3
2004 3
2005 1
2006 2
2008 1
2009 3
2010 1
2011 4
2012 4
2013 3
2014 4
2015 3
2016 5
2017 5
2018 5
2019 2
2020 3
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K. Saeki H, et al. Among authors: katsunuma t. J Dermatol. 2022 Oct;49(10):e315-e375. doi: 10.1111/1346-8138.16527. Epub 2022 Aug 22. J Dermatol. 2022. PMID: 35996152
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021.
Saeki H, Ohya Y, Furuta J, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021, The Japanese Society of Allergology, The Japanese Dermatology Association. Saeki H, et al. Among authors: katsunuma t. Allergol Int. 2022 Oct;71(4):448-458. doi: 10.1016/j.alit.2022.06.009. Epub 2022 Sep 2. Allergol Int. 2022. PMID: 36064654 Free article. Review.
Sinobronchial syndrome treated as intractable asthma.
Suzuki R, Sugimura K, Akashi K, Katsunuma T. Suzuki R, et al. Among authors: katsunuma t. Pediatr Int. 2018 Oct;60(10):979-981. doi: 10.1111/ped.13677. Epub 2018 Oct 15. Pediatr Int. 2018. PMID: 30320426 No abstract available.
Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study.
Igarashi A, Katsunuma T, Matsumura T, Komazaki H; Nemolizumab-JP04 Study Group. Igarashi A, et al. Among authors: katsunuma t. Br J Dermatol. 2023 Dec 20;190(1):20-28. doi: 10.1093/bjd/ljad268. Br J Dermatol. 2023. PMID: 37522351 Clinical Trial.
Effect of oral immunotherapy in children with milk allergy: The ORIMA study.
Maeda M, Imai T, Ishikawa R, Nakamura T, Kamiya T, Kimura A, Fujita S, Akashi K, Tada H, Morita H, Matsumoto K, Katsunuma T. Maeda M, et al. Among authors: katsunuma t. Allergol Int. 2021 Apr;70(2):223-228. doi: 10.1016/j.alit.2020.09.011. Epub 2020 Nov 25. Allergol Int. 2021. PMID: 33248880 Free article. Clinical Trial.
138 results